Active Ingredient History
Mannitol is a type of sugar alcohol used as a sweetener and medication. It is used as a low calorie sweetener as it is poorly absorbed by the intestines. As a medication, it is used to decrease pressure in the eyes, as in glaucoma, and to lower increased intracranial pressure. Medically, it is given by injection or inhalation. Effects typically begin within 15 minutes and last up to 8 hours. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Diuretics, Osmotic (approved 1964)
Acute Kidney Injury (Phase 2)
Airway Management (Early Phase 1)
Alcohol-Induced Disorders (Phase 3)
Anesthesia (Phase 4)
Asthma (Phase 4)
Astrocytoma (Phase 2)
Blood Pressure (Phase 1)
Body Fluids (Phase 4)
Bone Marrow Diseases (Phase 1)
Brain Contusion (Phase 1/Phase 2)
Brain Diseases (Phase 3)
Brain Edema (Phase 4)
Brain Injuries (Phase 2/Phase 3)
Brain Injuries, Traumatic (Phase 4)
Brain Neoplasms (Phase 2)
Bronchiectasis (Phase 3)
Burns (Phase 1)
Ciguatoxins (Phase 3)
Cockayne Syndrome (Phase 1/Phase 2)
Colonoscopy (Phase 4)
Constipation (Phase 4)
Coronary Artery Disease (Phase 3)
COVID-19 (Phase 2/Phase 3)
Craniocerebral Trauma (Phase 1/Phase 2)
Cystic Fibrosis (Phase 3)
Diabetes Mellitus (Phase 1/Phase 2)
Diabetic Retinopathy (Phase 4)
Drug-Related Side Effects and Adverse Reactions (Phase 2/Phase 3)
Epidermal Growth Factor (Phase 1/Phase 2)
Fetal Hypoxia (Phase 3)
Gait (Phase 2/Phase 3)
Gastroenteritis (Phase 1/Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 2)
Headache (Phase 4)
Healthy Volunteers (Phase 1/Phase 2)
Hearing Loss (Phase 2)
Heart Diseases (Phase 3)
Hematoma, Subdural (Phase 1/Phase 2)
Hemodialysis, Home (Phase 2/Phase 3)
Hemodilution (Phase 3)
Hemodynamics (Phase 2/Phase 3)
Hypersensitivity (Early Phase 1)
Hypotension (Phase 2)
Hypoxia-Ischemia, Brain (Phase 3)
Infant, Newborn, Diseases (Phase 3)
Inflammation (Phase 4)
Injections (Phase 2/Phase 3)
Intestinal Neoplasms (Phase 1)
Intracranial Hypertension (Phase 4)
Intracranial Pressure (Phase 4)
Kidney Diseases (Phase 2/Phase 3)
Kidney Neoplasms (Phase 3)
Kidney Transplantation (Phase 3)
Lung Diseases, Obstructive (Phase 2)
Lymphoma (Phase 1/Phase 2)
Malaria, Cerebral (Phase 3)
Medulloblastoma (Phase 1/Phase 2)
Metabolic Diseases (Phase 4)
Mortality (Phase 2)
Neoplasms (Phase 1)
Neoplasms, Germ Cell and Embryonal (Phase 1/Phase 2)
Neuralgia, Postherpetic (Phase 1/Phase 2)
Neuroectodermal Tumors (Phase 1/Phase 2)
Neuroectodermal Tumors, Primitive (Phase 1/Phase 2)
Neuroprotection (Phase 3)
Norovirus (Phase 1/Phase 2)
Oligodendroglioma (Phase 1/Phase 2)
Opioid-Related Disorders (Phase 2)
Osmotic Pressure (Phase 4)
Osteoarthritis, Knee (Phase 2/Phase 3)
Pain (Phase 1)
Parkinson Disease (Phase 2)
Pneumonia (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 1/Phase 2)
Pulpitis (Phase 2/Phase 3)
Radiation Oncology (Phase 2)
Reperfusion Injury (Phase 3)
Respiratory Sounds (Phase 3)
Shock, Septic (Phase 3)
Sleep Apnea, Obstructive (Phase 2/Phase 3)
Sodium Lactate (Phase 3)
Stress, Physiological (Phase 3)
Stress, Psychological (Phase 3)
Stroke (Phase 2)
Traumatology (Phase 1/Phase 2)
Ureteral Diseases (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
